You have 9 free searches left this month | for more free features.

City

Hyderabad (1)

Panchkula (1)

Richmond (1)

Condition

NAFLD (3)

Dyslipidemias (1)

Fatty Liver (1)

Liver Transplant; Complications (1)

Metabolic Syndrome (1)

Obesity (1)

Type 2 Diabetes (1)

Overall Status

Unknown status (2)

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 3 (2)

phase 2 (1)

phase 4 (1)

Sponsor

Asian Institute of Gastroenterology, India (1)

Command Hospital, India (1)

Zydus Lifesciences Limited (1)

Zydus Therapeutics Inc. (1)

Collaborator

Intervention

saroglitazar (4)

combination drug (1)

lifestyle changes (1)

pioglitazone (1)

vitamin e (1)

Study Documents

Intervention Type

drug (4)

behavioral (1)

Funder Type

Industry (2)

Other (2)

Study Type

Interventional (4)

saroglitazar

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

NAFLD, Obesity, Type 2 Diabetes Trial (Saroglitazar)

Not yet recruiting

NAFLD
+4 more

Saroglitazar

(no location specified)

May 25, 2023

Liver Transplant; Complications, NAFLD Trial in Richmond (Saroglitazar)

Recruiting

Liver Transplant; Complications
NAFLD

Saroglitazar

Richmond, Virginia

Virginia Commonwealth University

Apr 23, 2022

NAFLD Trial in Hyderabad (Saroglitazar, Vitamin E, Combination drug)

Unknown status

NAFLD

Saroglitazar
+3 more

Hyderabad, Telangana, India

Asian Institute of Gastroenterology Hospitals

Jan 24, 2021

Fatty Liver Trial in Panchkula (Saroglitazar, Pioglitazone)

Unknown status

Fatty Liver

Saroglitazar
Pioglitazone

Panchkula, Haryana, India

Command Hospital

Oct 14, 2014